-
Healthspring felicitated at Economic Times @ET_Edge Best Healthcare Brands Conference in Delhi!
- January 11, 2024
- Posted by: jaymanpandya
- Category: Uncategorized
No CommentsHealthspring felicitated at Economic Times @ET_Edge Best Healthcare Brands Conference in Delhi! Proud Healthspringer!!#ETBestHealthcareBrands #Healthcare #HealthcareIndustry #HealthcareServices #ETBestHealthcareBrands2023 #familyhealth #primaryhealthcare #preventivehealthcare pic.twitter.com/VfqLHdzZ5d — Healthspring Family Health Experts (@TheHealthspring) June 30, 2023
-
Sabre Partners Net Zero Initiative
- January 11, 2024
- Posted by: jaymanpandya
- Category: Uncategorized
Please read the PDF from here
-
Aviom India Housing Finance Private Limited : Rating Rationale
- January 11, 2024
- Posted by: jaymanpandya
- Category: Uncategorized
This article was originally posted on: https://www.crisilratings.com/mnt/winshare/Ratings/RatingList/RatingDocs/AviomIndiaHousingFinancePrivateLimited_May%2018,%202023_RR_318688.html Download the Rating Rationale PDF from here Rating Rationale May 18, 2023 | Mumbai Aviom India Housing Finance Private Limited Rating upgraded to ‘CRISIL BBB+/Stable’; Rated amount enhanced for Bank Debt Rating Action Total Bank Loan Facilities Rated Rs.125 Crore (Enhanced from Rs.25 Crore) Long Term Rating CRISIL
-
Mylab and Ekincare to promote Serum Institute’s nasal flu vaccine among corporates
- January 11, 2024
- Posted by: jaymanpandya
- Category: Uncategorized
This article was originally posted on: https://www.thehindubusinessline.com/news/national/mylab-and-ekincare-to-promote-serum-institutes-nasal-flu-vaccine-among-corporates/article67579438.ece Coverage in Economic Times can be read on: https://health.economictimes.indiatimes.com/news/diagnostics/mylab-collaborates-with-ekincare-to-promote-nasovac-s4-influenza-nasal-vaccine/105562482 Ekincare is a corporate health benefits platform and its collaboration with Mylab will enable businesses to incorporate NASOVAC-S4 into their employee wellness programs Diagnostics solutions provider Mylab is partnering with Ekincare to promote the nasal influenza vaccine NASOVAC-S4, developed